Rantanen, Taina
Pynnönen, Katja
Saajanaho, Milla
Siltanen, Sini
Karavirta, Laura
Kokko, Katja
Karvonen, Anu
Kauppinen, Markku
Rantalainen, Timo
Rantakokko, Merja
Portegijs, Erja
Hassandra, Mary http://orcid.org/0000-0001-8046-3547
Funding for this research was provided by:
H2020 European Research Council (693045)
Article History
Received: 18 May 2018
Accepted: 11 December 2018
First Online: 7 January 2019
Ethics approval and consent to participate
: The ethical committee of the Central Finland Hospital district provided an ethical approval pertaining to the AGNES cohort and intervention studies on August 23, 2017. Consent to participate procedure starts after the laboratory assessments of the cohort study, with a short verbal briefing and written information, including a consent form that they can read at their leisure. Within 2 weeks, the intervention counsellor will call potential participants to confirm their willingness to participate in the study and, if necessary, to provide them with additional information on the study. Once the participant has provided verbal consent, the signed written informed consent form will be returned by post or in person. In case of important protocol changes, a new ethical statement will be requested and new informed consent procedures initiated for participants. The AGNES intervention study follows the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.